• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义结直肠癌分子亚型的分类系统的协调:相互关系及临床意义。

Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications.

作者信息

Sadanandam Anguraj, Wang Xin, de Sousa E Melo Felipe, Gray Joe W, Vermeulen Louis, Hanahan Douglas, Medema Jan Paul

机构信息

Swiss Institute of Bioinformatics; Lausanne, Switzerland; Swiss Institute for Experimental Cancer Research; Swiss Federal Institute of Technology Lausanne (EPFL); Lausanne, Switzerland.

Cancer Research UK Cambridge Institute; University of Cambridge; Cambridge, UK.

出版信息

Cell Cycle. 2014;13(3):353-7. doi: 10.4161/cc.27769. Epub 2014 Jan 9.

DOI:10.4161/cc.27769
PMID:24406433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3956531/
Abstract

Recently we published two independent studies describing novel gene expression-based classifications of colorectal cancer (CRC). Notably, each study stratified CRC into a different number of subtypes: one reported 3 subtypes, whereas the second highlighted 5. Given that each ascribed clinical significance, distinctive biology, and therapeutic prognosis to the different subtypes, we sought to reconcile this apparent incongruity in subtype stratification of CRC, and to interrelate the results. To do so, we each evaluated the other's data sets and analytical methods and discovered that the subtypes and their classifiers are, in fact, clearly related to each other; indeed, the 5 subtype outcomes can be coalesced into the same three. In addition to presenting this clarification, we briefly discuss how both classification methods can be viewed within the broader literature on CRC subtypes, and potentially applied.

摘要

最近我们发表了两项独立研究,描述了基于基因表达的新型结直肠癌(CRC)分类。值得注意的是,每项研究将CRC分层为不同数量的亚型:一项报告了3个亚型,而另一项则强调了5个亚型。鉴于每项研究都赋予了不同亚型临床意义、独特生物学特性和治疗预后,我们试图调和CRC亚型分层中这种明显的不一致,并将结果相互关联。为此,我们各自评估了对方的数据集和分析方法,发现这些亚型及其分类器实际上彼此明显相关;事实上,5个亚型的结果可以合并为相同的3个。除了给出这一解释外,我们还简要讨论了这两种分类方法如何在关于CRC亚型的更广泛文献中看待,以及可能的应用方式。

相似文献

1
Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications.定义结直肠癌分子亚型的分类系统的协调:相互关系及临床意义。
Cell Cycle. 2014;13(3):353-7. doi: 10.4161/cc.27769. Epub 2014 Jan 9.
2
Gastrointestinal cancer: turning up trumps for new CRC subtypes.胃肠道癌症:新的结直肠癌亚型的制胜法宝
Nat Rev Clin Oncol. 2013 Jun;10(6):303. doi: 10.1038/nrclinonc.2013.71. Epub 2013 May 7.
3
Gene expression: colorectal cancer classifications.基因表达:结直肠癌分类
Nat Rev Cancer. 2013 Jun;13(6):380-1. doi: 10.1038/nrc3529. Epub 2013 May 3.
4
Colorectal cancer: Is the new era of colorectal cancer classification finally here?结直肠癌:结直肠癌分类的新时代终于来临了吗?
Nat Rev Gastroenterol Hepatol. 2013 Jul;10(7):391-3. doi: 10.1038/nrgastro.2013.90. Epub 2013 May 21.
5
A colorectal cancer classification system that associates cellular phenotype and responses to therapy.一种与细胞表型和治疗反应相关的结直肠癌分类系统。
Nat Med. 2013 May;19(5):619-25. doi: 10.1038/nm.3175. Epub 2013 Apr 14.
6
External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS.基于微卫星不稳定性、CIMP、BRAF 和 KRAS 的结直肠癌分子亚型分类的外部验证。
BMC Cancer. 2019 Jul 11;19(1):681. doi: 10.1186/s12885-019-5842-7.
7
Simple classifiers for molecular subtypes of colorectal cancer.用于结直肠癌分子亚型的简易分类器。
Arab J Gastroenterol. 2017 Dec;18(4):191-200. doi: 10.1016/j.ajg.2017.11.007. Epub 2017 Dec 11.
8
Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.从结直肠活检中对稳健的肿瘤细胞内在亚型进行前瞻性患者分层。
J Pathol. 2018 May;245(1):19-28. doi: 10.1002/path.5051. Epub 2018 Mar 25.
9
Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines.原发性结直肠肿瘤的亚型与结直肠细胞系中靶向治疗的反应相关。
BMC Med Genomics. 2012 Dec 31;5:66. doi: 10.1186/1755-8794-5-66.
10
Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system.基于修订后的CIMP分类系统的两种CIMP阳性结直肠癌亚型的不同临床结局
Br J Cancer. 2017 Apr 11;116(8):1012-1020. doi: 10.1038/bjc.2017.52. Epub 2017 Mar 9.

引用本文的文献

1
Controversies and Perspectives in the Current Management of Patients with Locally Advanced Rectal Cancer-A Systematic Review.局部晚期直肠癌患者当前管理中的争议与展望——一项系统综述
Life (Basel). 2025 Jun 25;15(7):1011. doi: 10.3390/life15071011.
2
Dietary vitamin D intake and risk of colorectal cancer according to vitamin D receptor expression in tumors and their surrounding stroma.饮食维生素 D 摄入与肿瘤及其周围基质中维生素 D 受体表达的结直肠癌风险。
J Gastroenterol. 2024 Sep;59(9):825-835. doi: 10.1007/s00535-024-02129-4. Epub 2024 Jun 20.
3
Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study.转移性结直肠癌患者在真实世界中分为共识分子亚型的研究:一项试点研究。
World J Clin Oncol. 2023 Oct 24;14(10):409-419. doi: 10.5306/wjco.v14.i10.409.
4
Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques.结直肠癌(CRC)中细胞增殖的预后生物标志物:从免疫组织化学到分子生物学技术
Cancers (Basel). 2023 Sep 15;15(18):4570. doi: 10.3390/cancers15184570.
5
Unsupervised machine learning-based clustering identifies unique molecular signatures of colorectal cancer with distinct clinical outcomes.基于无监督机器学习的聚类分析识别出具有不同临床结局的结直肠癌独特分子特征。
Genes Dis. 2023 Mar 24;10(6):2270-2273. doi: 10.1016/j.gendis.2023.01.023. eCollection 2023 Nov.
6
Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers.钙调蛋白在癌症中的新作用:结直肠癌及其他癌症的潜在生物标志物
World J Gastrointest Oncol. 2022 Sep 15;14(9):1637-1653. doi: 10.4251/wjgo.v14.i9.1637.
7
αSMA fibroblasts suppress Lgr5 cancer stem cells and restrain colorectal cancer progression.αSMA 成纤维细胞抑制 Lgr5 癌症干细胞并抑制结直肠癌细胞的进展。
Oncogene. 2021 Jul;40(26):4440-4452. doi: 10.1038/s41388-021-01866-7. Epub 2021 Jun 9.
8
Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine.结直肠癌的分子亚型:个性化医疗中一个新兴的治疗机会。
Genes Dis. 2019 Oct 30;8(2):133-145. doi: 10.1016/j.gendis.2019.10.013. eCollection 2021 Mar.
9
Pharmaceutical immunoglobulin G impairs anti-carcinoma activity of oxaliplatin in colon cancer cells.药物免疫球蛋白 G 削弱奥沙利铂对结肠癌细胞的抗癌活性。
Br J Cancer. 2021 Apr;124(8):1411-1420. doi: 10.1038/s41416-021-01272-6. Epub 2021 Feb 9.
10
Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges.探索和建模结肠癌肿瘤间异质性:机遇与挑战。
Oncogenesis. 2020 Jul 9;9(7):66. doi: 10.1038/s41389-020-00250-6.

本文引用的文献

1
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions.预后不良的结肠癌由分子上明显不同的亚型定义,并由锯齿状前体病变发展而来。
Nat Med. 2013 May;19(5):614-8. doi: 10.1038/nm.3174. Epub 2013 Apr 14.
2
A colorectal cancer classification system that associates cellular phenotype and responses to therapy.一种与细胞表型和治疗反应相关的结直肠癌分类系统。
Nat Med. 2013 May;19(5):619-25. doi: 10.1038/nm.3175. Epub 2013 Apr 14.
3
Comprehensive molecular characterization of human colon and rectal cancer.全面的人类结肠和直肠癌分子特征分析。
Nature. 2012 Jul 18;487(7407):330-7. doi: 10.1038/nature11252.
4
Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients.癌症干细胞相关 Wnt 靶基因甲基化预示结直肠癌患者预后不良。
Cell Stem Cell. 2011 Nov 4;9(5):476-85. doi: 10.1016/j.stem.2011.10.008.
5
The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse.肠干细胞特征可识别结直肠肿瘤干细胞,并可预测疾病复发。
Cell Stem Cell. 2011 May 6;8(5):511-24. doi: 10.1016/j.stem.2011.02.020. Epub 2011 Mar 17.
6
Microsatellite instability in colorectal cancer.结直肠癌中的微卫星不稳定性。
Gastroenterology. 2010 Jun;138(6):2073-2087.e3. doi: 10.1053/j.gastro.2009.12.064.
7
Frozen robust multiarray analysis (fRMA).冻融稳健多阵列分析(fRMA)。
Biostatistics. 2010 Apr;11(2):242-53. doi: 10.1093/biostatistics/kxp059. Epub 2010 Jan 22.
8
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab.KRAS野生型状态可预测转移性结直肠癌患者接受西妥昔单抗治疗后的生存期,并与早期放射学反应相关。
Ann Oncol. 2008 Mar;19(3):508-15. doi: 10.1093/annonc/mdm496. Epub 2007 Nov 12.
9
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.埃皮瑞利素、双调蛋白的表达及K-ras突变状态可预测接受西妥昔单抗治疗的转移性结直肠癌患者的疾病控制情况。
J Clin Oncol. 2007 Aug 1;25(22):3230-7. doi: 10.1200/JCO.2006.10.5437.
10
Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?将基因表达谱分析应用于临床:分子特征何时会与患者护理相关?
Nat Rev Cancer. 2007 Jul;7(7):545-53. doi: 10.1038/nrc2173.